Megan E. Piper , Jesse T. Kaye , Thomas M. Piasecki , James J. Yang , Anne Buu
{"title":"吸烟的成年人吸食大麻:与从燃烧香烟转向电子烟或低尼古丁香烟的关系","authors":"Megan E. Piper , Jesse T. Kaye , Thomas M. Piasecki , James J. Yang , Anne Buu","doi":"10.1016/j.drugalcdep.2025.112821","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Evidence is mixed regarding whether cannabis use impairs tobacco smoking cessation. This study tests the hypothesis that people who co-use tobacco and cannabis are less likely to switch to an alternative tobacco product when asked to do so.</div></div><div><h3>Study design</h3><div>Secondary data analysis of a mixed design with a within-subjects factor (active nicotine patch vs. placebo patch) and a between-subjects factor (study product). Participants sampled their assigned study product for 1 week, then were asked not to smoke their usual brand cigarettes and use only their study product and the study patches for 1 week (a switch week). A washout week was followed by a second switch week during which participants used the other patch type.</div></div><div><h3>Setting/participants</h3><div>Research office. Adults not motivated to quit smoking who smoke ≥ 5 cigarettes/day.</div></div><div><h3>Intervention</h3><div>Study products (very low nicotine cigarettes [VLNCs], e-cigarettes or no product) were provided for 4 weeks and 1 week of active nicotine patches and 1 week of placebo patches were provided in double-blind and counterbalanced fashion, for the switch weeks.</div></div><div><h3>Main outcome measures</h3><div>Number of usual brand cigarettes smoked during the switch weeks.</div></div><div><h3>Results</h3><div>Data collected September 2019-June 2022 and analyzed November-December 2024. Participants who reported past 30-day co-use of cannabis at baseline (n = 56) smoked significantly more usual brand cigarettes during switch weeks than those who did not co-use (n = 104; p = .03) and were less likely to make a tobacco cessation attempt (p < .05).</div></div><div><h3>Conclusions</h3><div>Cannabis use is associated with less switching from cigarettes to VLNCs or e-cigarettes.</div></div><div><h3>Trial registration</h3><div>Clinicaltrials.gov (NCT04084210).</div></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"275 ","pages":"Article 112821"},"PeriodicalIF":3.6000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cannabis use among adults who smoke tobacco: Relations with switching from combusted cigarettes to e-cigarettes or very low nicotine cigarettes\",\"authors\":\"Megan E. Piper , Jesse T. Kaye , Thomas M. Piasecki , James J. Yang , Anne Buu\",\"doi\":\"10.1016/j.drugalcdep.2025.112821\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Evidence is mixed regarding whether cannabis use impairs tobacco smoking cessation. This study tests the hypothesis that people who co-use tobacco and cannabis are less likely to switch to an alternative tobacco product when asked to do so.</div></div><div><h3>Study design</h3><div>Secondary data analysis of a mixed design with a within-subjects factor (active nicotine patch vs. placebo patch) and a between-subjects factor (study product). Participants sampled their assigned study product for 1 week, then were asked not to smoke their usual brand cigarettes and use only their study product and the study patches for 1 week (a switch week). A washout week was followed by a second switch week during which participants used the other patch type.</div></div><div><h3>Setting/participants</h3><div>Research office. Adults not motivated to quit smoking who smoke ≥ 5 cigarettes/day.</div></div><div><h3>Intervention</h3><div>Study products (very low nicotine cigarettes [VLNCs], e-cigarettes or no product) were provided for 4 weeks and 1 week of active nicotine patches and 1 week of placebo patches were provided in double-blind and counterbalanced fashion, for the switch weeks.</div></div><div><h3>Main outcome measures</h3><div>Number of usual brand cigarettes smoked during the switch weeks.</div></div><div><h3>Results</h3><div>Data collected September 2019-June 2022 and analyzed November-December 2024. Participants who reported past 30-day co-use of cannabis at baseline (n = 56) smoked significantly more usual brand cigarettes during switch weeks than those who did not co-use (n = 104; p = .03) and were less likely to make a tobacco cessation attempt (p < .05).</div></div><div><h3>Conclusions</h3><div>Cannabis use is associated with less switching from cigarettes to VLNCs or e-cigarettes.</div></div><div><h3>Trial registration</h3><div>Clinicaltrials.gov (NCT04084210).</div></div>\",\"PeriodicalId\":11322,\"journal\":{\"name\":\"Drug and alcohol dependence\",\"volume\":\"275 \",\"pages\":\"Article 112821\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and alcohol dependence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0376871625002741\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0376871625002741","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Cannabis use among adults who smoke tobacco: Relations with switching from combusted cigarettes to e-cigarettes or very low nicotine cigarettes
Introduction
Evidence is mixed regarding whether cannabis use impairs tobacco smoking cessation. This study tests the hypothesis that people who co-use tobacco and cannabis are less likely to switch to an alternative tobacco product when asked to do so.
Study design
Secondary data analysis of a mixed design with a within-subjects factor (active nicotine patch vs. placebo patch) and a between-subjects factor (study product). Participants sampled their assigned study product for 1 week, then were asked not to smoke their usual brand cigarettes and use only their study product and the study patches for 1 week (a switch week). A washout week was followed by a second switch week during which participants used the other patch type.
Setting/participants
Research office. Adults not motivated to quit smoking who smoke ≥ 5 cigarettes/day.
Intervention
Study products (very low nicotine cigarettes [VLNCs], e-cigarettes or no product) were provided for 4 weeks and 1 week of active nicotine patches and 1 week of placebo patches were provided in double-blind and counterbalanced fashion, for the switch weeks.
Main outcome measures
Number of usual brand cigarettes smoked during the switch weeks.
Results
Data collected September 2019-June 2022 and analyzed November-December 2024. Participants who reported past 30-day co-use of cannabis at baseline (n = 56) smoked significantly more usual brand cigarettes during switch weeks than those who did not co-use (n = 104; p = .03) and were less likely to make a tobacco cessation attempt (p < .05).
Conclusions
Cannabis use is associated with less switching from cigarettes to VLNCs or e-cigarettes.
期刊介绍:
Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.